Menno de Winther

Menno de Winther

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Cell Reports
Verified
Journal Article
Open access
Jan Van den BosscheJan Van den Bossche
Jan Van den Bossche
JBJeroen Baardman
Jeroen Baardman
NONatasja Anna Otto
Natasja Anna Otto
SVSaskia van der Velden
Saskia van der Velden
ANAnnette E. Neele
Annette E. Neele
MWMenno de Winther
Menno de Winther
Macrophages are innate immune cells that adopt diverse activation states in response to their microenvironment. Editing macrophage activation to dampen inflammatory diseases by promoting the repolarization of inflammatory (M1) macrophages to anti-inflammatory (M2) macrophages is of high interest. Here, we find that mouse and human M1 macrophages fail to convert into M2 cells upon IL-4 exposure in vitro and in vivo. In sharp contrast, M2 macrophages are more plastic and readily repolarized into an inflammatory M1 state. We identify M1-associated inhibition of mitochondrial oxidative phosphorylation as the factor responsible for preventing M1→M2 repolarization. Inhibiting nitric oxide production, a key effector molecule in M1 cells, dampens the decline in mitochondrial function to improve metabolic and phenotypic reprogramming to M2 macrophages. Thus, inflammatory macrophage activation blunts oxidative phosphorylation, thereby preventing repolarization. Therapeutically restoring mitochondrial function might be useful to improve the reprogramming of inflammatory macrophages into anti-inflammatory cells to control disease.

8 September 2013 in Angiogenesis
Verified
Journal Article
Closed access
PDF file
NJNadine Jetten
Nadine Jetten
SVSanne Verbruggen
Sanne Verbruggen
MGMarion J. Gijbels
Marion J. Gijbels
MPMark J. Post
Mark J. Post
MWMenno de Winther
Menno de Winther
MDMarjo M. P. C. Donners
Marjo M. P. C. Donners

6 November 2020 in Circulation Research
Verified
Journal Article
Open access
PDF file
MDMarie Depuydt
Marie Depuydt
KPKoen H.M. Prange
Koen H.M. Prange
LSLotte Slenders
Lotte Slenders
TÖTiit Örd
Tiit Örd
DEDanny Elbersen
Danny Elbersen
GPGerard Pasterkamp
Gerard Pasterkamp
Rationale: Atherosclerotic lesions are known for their cellular heterogeneity, yet the molecular complexity within the cells of human plaques has not been fully assessed. Objective: Using single-cell transcriptomics and chromatin accessibility, we gained a better understanding of the pathophysiology underlying human atherosclerosis. Methods and Results: We performed single-cell RNA and single-cell ATAC sequencing on human carotid atherosclerotic plaques to define the cells at play and determine their transcriptomic and epigenomic characteristics. We identified 14 distinct cell populations including endothelial cells, smooth muscle cells, mast cells, B cells, myeloid cells, and T cells and identified multiple cellular activation states and suggested cellular interconversions. Within the endothelial cell population, we defined subsets with angiogenic capacity plus clear signs of endothelial to mesenchymal transition. CD4 + and CD8 + T cells showed activation-based subclasses, each with a gradual decline from a cytotoxic to a more quiescent phenotype. Myeloid cells included 2 populations of proinflammatory macrophages showing IL (interleukin) 1B or TNF (tumor necrosis factor) expression as well as a foam cell-like population expressing TREM2 (triggering receptor expressed on myeloid cells 2) and displaying a fibrosis-promoting phenotype. ATACseq data identified specific transcription factors associated with the myeloid subpopulation and T cell cytokine profiles underlying mutual activation between both cell types. Finally, cardiovascular disease susceptibility genes identified using public genome-wide association studies data were particularly enriched in lesional macrophages, endothelial, and smooth muscle cells. Conclusions: This study provides a transcriptome-based cellular landscape of human atherosclerotic plaques and highlights cellular plasticity and intercellular communication at the site of disease. This detailed definition of cell communities at play in atherosclerosis will facilitate cell-based mapping of novel interventional targets with direct functional relevance for the treatment of human disease.

1 December 2012 in Atherosclerosis
Verified
Journal Article
Closed access
Lauran StögerLauran Stöger
Lauran Stöger
MGMarion J.J. Gijbels
Marion J.J. Gijbels
SVSaskia van der Velden
Saskia van der Velden
Marco MancaMarco Manca
Marco Manca
CLChris M. van der Loos
Chris M. van der Loos
MWMenno de Winther
Menno de Winther

1 May 2005 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
MWMenno de Winther
Menno de Winther
EKEdwin Kanters
Edwin Kanters
GKGeorg Kraal
Georg Kraal
MHMarten H. Hofker
Marten H. Hofker
Atherosclerosis is an inflammatory disease, characterized by the accumulation of macrophage-derived foam cells in the vessel wall and accompanied by the production of a wide range of chemokines, cytokines, and growth factors. These factors regulate the turnover and differentiation of immigrating and resident cells, eventually influencing plaque development. One of the key regulators of inflammation is the transcription factor nuclear factor κB (NF-κB), which, for a long time, has been regarded as a proatherogenic factor, mainly because of its regulation of many of the proinflammatory genes linked to atherosclerosis. NF-κB may play an important role in guarding the delicate balance of the atherosclerotic process as a direct regulator of proinflammatory and anti-inflammatory genes and as a regulator of cell survival and proliferation. Here we address recent literature on the function of NF-κB in inflammatory responses and its relation to atherosclerosis.

1 November 2009 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
BVBetty S. van der Veen
Betty S. van der Veen
MWMenno de Winther
Menno de Winther
PHPeter Heeringa
Peter Heeringa
Myeloperoxidase (MPO) is a heme-containing peroxidase abundantly expressed in neutrophils and to a lesser extent in monocytes. Enzymatically active MPO, together with hydrogen peroxide and chloride, produces the powerful oxidant hypochlorous acid and is a key contributor to the oxygen-dependent microbicidal activity of phagocytes. In addition, excessive generation of MPO-derived oxidants has been linked to tissue damage in many diseases, especially those characterized by acute or chronic inflammation. It has become increasingly clear that MPO exerts effects that are beyond its oxidative properties. These properties of MPO are, in many cases, independent of its catalytic activity and affect various processes involved in cell signaling and cell–cell interactions and are, as such, capable of modulating inflammatory responses. Given these diverse effects, an increased interest has emerged in the role of MPO and its downstream products in a wide range of inflammatory diseases. In this article, our knowledge pertaining to the biologic role of MPO and its downstream effects and mechanisms of action in health and disease is reviewed and discussed. Antioxid. Redox Signal. 11, 2899–2937.